|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Common Stock Including Additional Paid in Capital | |||||
| Total net income | |||||
| Provision for Loan, Lease, and Other Losses | |||||
| Adjustments to reconcile net income from operations to net cash provided by operating activities: | |||||
| Provision for (reversal of) credit losses | |||||
| Net loss (gain) on disposal of premises and equipment | |||||
| Depreciation and amortization | |||||
| Net (discount) premium amortization on investment securities | |||||
| Net (gain) loss on investment securities transactions | |||||
| Realized and unrealized net gains on mortgage banking activities | |||||
| Net gain on sale of OREO | |||||
| Write-downs of OREO and other assets pending disposal | |||||
| Net gains and write-downs of OREO and other assets pending disposal | |||||
| Gain (Loss) on Extinguishment of Debt | |||||
| Mortgage servicing rights impairment (recovery) | |||||
| Valuation allowance for loans held-for-sale | |||||
| Deferred Income Tax Expense (Benefit) | |||||
| Life Insurance, Corporate or Bank Owned, Change in Value | |||||
| Stock-based compensation expense | |||||
| Common Stock Including Additional Paid in Capital | |||||
| Total stock-based compensation expense | |||||
| Payment for Origination, Loan, Mortgage, Held-for-Sale | |||||
| Proceeds from Sale, Loan, Mortgage, Held-for-Sale | |||||
| Gain on sale of consumer credit card loans | |||||
| Gain on sale of branches, net | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease (increase) in accrued interest receivable | |||||
| Decrease (increase) in other assets | |||||
| (Decrease) increase in accrued interest payable | |||||
| (Decrease) increase in accounts payable and accrued expenses | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investment securities: | |||||
| Held-to-maturity | |||||
| Payments to Acquire Debt Securities, Available-for-Sale | |||||
| Proceeds from maturities, pay-downs, calls and sales of investment securities: | |||||
| Held-to-maturity | |||||
| Available-for-sale | |||||
| Purchases of Federal Home Loan Bank and Federal Reserve Bank Stock | |||||
| Proceeds from Federal Home Loan Bank and Federal Reserve Bank Stock | |||||
| Payments for (Proceeds from) Short-Term Investments | |||||
| Proceeds from company-owned life insurance settlements | |||||
| Proceeds from sales of consumer credit card loans | |||||
| Net change in loans held for investment | |||||
| Proceeds from sale of OREO | |||||
| Proceeds from the sale of Health Savings Accounts | |||||
| Acquisition of bank and bank holding company, net of cash and cash equivalents received | |||||
| Net cash distributed in sale of branches | |||||
| Capital expenditures, net of sales | |||||
| Net cash provided by investing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Securities Purchased under Agreements to Resell, Increase | |||||
| Finite-Lived Intangible Assets, Gross | |||||
| Cash flows from financing activities: | |||||
| Net decrease in deposits | |||||
| Net decrease in securities sold under repurchase agreements | |||||
| Proceeds from (Repayments of) Other Debt | |||||
| Repayments of Other Long-term Debt | |||||
| Proceeds on long-term debt | |||||
| Payments of Stock Issuance Costs | |||||
| Proceeds from issuance of common stock | |||||
| Payments of Debt Issuance Costs | |||||
| Proceeds from Issuance of Subordinated Long-Term Debt | |||||
| Dividends paid to common stockholders | |||||
| Net cash used in financing activities | |||||
| Supplemental schedule of noncash investing activities from acquisitions: | |||||
| Investment securities | |||||
| Loans held for sale | |||||
| Loans held for investment, net | |||||
| Premises and equipment | |||||
| Goodwill | |||||
| Other intangibles | |||||
| Mortgage servicing rights | |||||
| Company-owned life insurance | |||||
| Deferred tax assets | |||||
| Other real estate owned | |||||
| Other assets | |||||
| Total noncash assets acquired | |||||
| Deposits | |||||
| Securities sold under repurchase agreements | |||||
| Accounts payable and accrued expenses | |||||
| Long-term debt | |||||
| Subordinated debentures held by subsidiary trusts | |||||
| Total liabilities assumed | |||||
| Supplemental disclosures of noncash investing and financing activities: | |||||
| Transfer of held-to-maturity to available-for-sale securities | |||||
| Non-cash transfer of securities from available-for-sale to held-to-maturity | |||||
| Transfer of Loans Held-for-sale to Portfolio Loans | |||||
| Amortization of unrealized gains and losses on transfers of securities | |||||
| Transfer of premises and equipment held-for-sale | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Transfer of loans to other real estate owned | |||||
| Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable | |||||
| Capitalization Of Internally Originated Mortgage Servicing Rights, Noncash Supplemental Disclosures | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for income taxes, net(1) | |||||
| Cash paid during the period for interest expense | |||||
Loading...